enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - imunosupresoare - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).
apo-go 5 mg/ml
genus pharmaceuticals limited - marea britanie - apomorfinum - sol. perf. in seringa preumpluta unidoza - 5mg/ml - agenti dopaminergici agonisti dopaminergici
apo-go 10 mg/ml
genus pharmaceuticals limited - marea britanie - apomorfinum - sol. inj. in pen multidoza - 10mg/ml - agenti dopaminergici agonisti dopaminergici
travoprost pharmathen international 30 micrograme/ml
pharmathen s.a. - grecia - travoprostum - pic. oft., sol - 30micrograme/ml - antiglaucomatoase si miotice analogi de prostaglandine
bortezomib biotech 3,5 mg
venus pharma gmbh - germania - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
pemetrexed ever pharma 25 mg/ml
ever pharma jena gmbh - germania - pemetrexedum - conc. pt. sol. perf. - 25mg/ml - antimetaboliti analogi ai acidului folic
bortezomib koanaa 3,5 mg
wave pharma limited - marea britanie - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice alte antineoplazice
everolimus mylan 10 mg
synthon hispania sl - spania - everolimus - compr. - 10mg - alte antineoplazice inhibitori de protein-kinaza
everolimus mylan 2,5 mg
synthon hispania sl - spania - everolimus - compr. - 2,5mg - alte antineoplazice inhibitori de protein-kinaza
everolimus mylan 5 mg
synthon hispania sl - spania - everolimus - compr. - 5mg - alte antineoplazice inhibitori de protein-kinaza